Skip to main content
ABUS logo

ABUS · Arbutus Biopharma Corp · Documents

Track ABUS — free
$4.02 -0.05 (-1.23%) At close · Nov 20 Q3 2024 earnings call transcript
Market Cap
$616.24M
Shares
153.29M
Volume · Nov 20 2.99M Avg daily vol (3M) 5.19M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024
Mar 5
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $18.14M ▼ 53.5% Net loss $72.85M Diluted EPS -$0.44
2023
Showing 51–100 of 197 documents
Key facts CIK 1447028 CUSIP 03879J100 13F (30d) 221 filings 200 filers Visit website Investor relations